Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic
-The Stroke Advisory Board brings together distinguished experts in neurology and stroke to support the advancement of its neural exosome...
Month: March 2024
RushNet Names Arizona Businessman Michael Cunha as Chairman and Chief Executive Officer
PHOENIX, AZ / ACCESSWIRE / March 4, 2024 / RushNet, Inc (OTC PINK:RSHN), (the "Company") announced today the appointment of...
MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
Ethics and regulatory approvals finalized for world-first take-home use of a psychedelic medicine MB22001 in placebo-controlled trial in depressed patients...
Redeye Initiates Coverage of PMD Device Solutions
STOCKHOLM, SE / ACCESSWIRE / March 04, 2024 / PMD Device Solutions (STO:PROMO) (FRA:8T0) Redeye assigns a base-case valuation of...
Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology
Vancouver, British Columbia--(Newsfile Corp. - March 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Pharmacy Associations Join Forces to Advocate for Pharmacists During Change Healthcare Outage
WASHINGTON, DC / ACCESSWIRE / March 3, 2024 / Association executives from the American Pharmacists Association (APhA), the National Community...
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused...
Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer
NON-REGULATORY PRESS RELEASE The NIPU trial is investigating the effect of adding UV1 vaccine to immunotherapy as second-line treatment of...
Dr. Robert T. Hoover II Joins Central Florida Foot & Ankle Institute’s New Location in AdventHealth Apopka’s Medical Plaza
Central Florida Foot & Ankle Institute Welcomes Esteemed Orlando Podiatrist Dr. Robert T. Hoover II to Its New Location at...
Malaysia Healthcare Travel Council Denies Allegations of Lack Of Direction in the Company
KUALA LUMPUR, Malaysia, March 02, 2024 (GLOBE NEWSWIRE) -- Malaysia Healthcare Travel Council (MHTC) would like to refer to the...
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical...
Brüush Receives Nasdaq Delisting Notification and Files to Appeal
VANCOUVER, BC / ACCESSWIRE / March 1, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it...
BioNxt Reports Completion of ODF Cladribine PK Study
VANCOUVER, BC / ACCESSWIRE / March 1, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
1933 Industries Issues Correction
VANCOUVER, BC / ACCESSWIRE / March 1, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused...
Adastra Holdings Announces Record Single Purchase Order For Over $1M
LANGLEY, BC / ACCESSWIRE / March 1, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2E) ("Adastra" or the "Company"), a leading cannabis...
Spakinect Announces CEO Transition: A New Era of Leadership and Innovation
SAN DIEGO, CA / ACCESSWIRE / March 1, 2024 / Today marks a significant milestone in the history of Spakinect...
Innsena Appoints Britteny Matero to Partner and Senior Vice President
Matero to lead Innsena’s market access line of business, drive collaborative efforts to improve care outcomes for underserved communities and...
Advocacy Groups Join Reagan-Udall Foundation and FDA for Workshop on Developing Biomarkers to Support Accelerated Approval in Rare Diseases
Workshop Presented Overwhelming Scientific Evidence to Support CSF-HS as a Primary Biomarker in Neuropathic MPS DisordersWASHINGTON, DC / ACCESSWIRE /...
Sonendo, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today...
RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals
London, United Kingdom--(Newsfile Corp. - March 1, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...